Download PDF
Drug Res (Stuttg) 2018; 68(03): 125-131
DOI: 10.1055/s-0043-119071
Review
© Georg Thieme Verlag KG Stuttgart · New York

Role of Drug Anesthesia and Cancer

Mahmoud Reza Moradkhani
1   Faculty of Medicine, Department of Anesthesiology, Lorestan University of Medical Sciences, Khoramabad, Iran
,
Arash Karimi
1   Faculty of Medicine, Department of Anesthesiology, Lorestan University of Medical Sciences, Khoramabad, Iran
› Author Affiliations
Further Information

Publication History

received 01 July 2017

accepted 09 August 2017

Publication Date:
21 November 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Mortality and morbidity rate among cancer patients is at an alarming rate and its ratio of incidence is increasing as a result of its effects of metastasis and recurrence in its patients. Anesthetists are faced with the challenges daily of handling and treating cancer patients, for surgical resection to removal of the primary tumor. Retrospective analyses and studies have proposed a link between anesthetic technique and cancer outcomes. In this mini-review, we will give a summary of some of the available effects of anesthetic and analgesic techniques on cancer metastasis as derived from experimental cell culture and live animal data and also from clinical studies.

Key words

anaesthesia - metastases - recurrence - cancer - analgesic techniques
 

  • References

  • 1 Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol 2012; 25: 376-384
    CrossrefPubMedGoogle Scholar
  • 2 Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105: 106-115
    CrossrefPubMedGoogle Scholar
  • 3 Kavanagh T, Buggy DJ. Can anaesthetic technique effect postoperative outcome?. Curr Opin Anaesthesiol 2012; 25: 185-198
    CrossrefPubMedGoogle Scholar
  • 4 Talmadge JE, Fidler IJ. AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res 2010; 70: 5649-5669
    CrossrefPubMedGoogle Scholar
  • 5 Fidler IJ. The pathogenesis of cancer metastasis: The “seed and soil” hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458
    CrossrefPubMedGoogle Scholar
  • 6 O’Riain SC, Buggy DJ, Kerin MJ. et al. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg 2005; 100: 244-249
    CrossrefPubMedGoogle Scholar
  • 7 Piegeler T, Votta-Velis EG, Liu G. et al. Antimetastatic potential of amide-linked local anesthetics: Inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology 2012; 117: 548-559
    CrossrefPubMedGoogle Scholar
  • 8 Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro. J Pharmacol Exp Ther 1999; 288: 660-664
    PubMedGoogle Scholar
  • 9 Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg 2006; 102: 1103-1107
    CrossrefPubMedGoogle Scholar
  • 10 Baptista-Hon DT, Robertson FM, Robertson GB. et al. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function. Br J Anaesth 2014; DOI: 10.1093/bja/aeu104.
    CrossrefPubMedGoogle Scholar
  • 11 Navada SC, Steinmann J, Lübbert M. et al. Clinical development of demethylating agents in hematology. J Clin Invest 2014; 124: 40-46
    CrossrefPubMedGoogle Scholar
  • 12 Lirk P, Hollmann MW, Fleischer M. et al. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth 2014; DOI: 10.1093/bja/aeu201.
    CrossrefPubMedGoogle Scholar
  • 13 Biki B, Mascha E, Moriarty DC. et al. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: A retrospective analysis. Anesthesiology 2008; 109: 180-187
    CrossrefPubMedGoogle Scholar
  • 14 Gottschalk A, Ford JG, Regelin CC. et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010; 113: 27-34
    CrossrefPubMedGoogle Scholar
  • 15 Buckley A, McQuaid S, Johnson P. et al. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: A pilot study. Br J Anaesth 2014; DOI: 10.1093/bja/aeu200.
    CrossrefPubMedGoogle Scholar
  • 16 Moselli NM, Baricocchi E, Ribero D. et al. Intraoperative epidural analgesia prevents the early proinflammatory response to surgical trauma. Results from a prospective randomized clinical trial of intraoperative epidural versus general analgesia. Ann Surg Oncol 2011; 18: 2722-2731
    CrossrefPubMedGoogle Scholar
  • 17 Forget P, De Kock M. Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity. Ann Fr Anesth Reanim 2009; 28: 751-768
    CrossrefPubMedGoogle Scholar
  • 18 Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?. Ann Surg Oncol 2003; 10: 972-992
    CrossrefPubMedGoogle Scholar
  • 19 Wada H, Seki S, Takahashi T. et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007; 106: 499-506
    CrossrefPubMedGoogle Scholar
  • 20 Bar-Yosef S, Melamed R, Page GG. et al. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001; 94: 1066-1073
    CrossrefPubMedGoogle Scholar
  • 21 Conrick-Martin I, Kell MR, Buggy DJ. Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function. J Clin Anesth 2012; 24: 3-7
    CrossrefPubMedGoogle Scholar
  • 22 Mao L, Lin S, Lin J. The effects of anesthetics on tumor progression. International journal of physiology, pathophysiology and pharmacology 2013; 5: 1
    PubMedGoogle Scholar
  • 23 Brackenbury WJ. Voltage-gated sodium channels and metastatic disease. Channels (Austin) 2012; 6: 352-361
    CrossrefPubMedGoogle Scholar
  • 24 House CD, Vaske CJ, Schwartz AM. et al. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 2010; 70: 6957-6967
    CrossrefPubMedGoogle Scholar
  • 25 Lucchinetti E, Awad AE, Rahman M. et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: Potential implications for tumor spreading and wound healing. Anesthesiology 2012; 116: 841-856
    CrossrefPubMedGoogle Scholar
  • 26 Yoon JR, Whipple RA, Balzer EM. et al. Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Res Treat 2011; 129: 691-701
    CrossrefPubMedGoogle Scholar
  • 27 Gupta K, Kshirsagar S, Chang L. et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002; 62: 4491-4498
    PubMedGoogle Scholar
  • 28 Fujioka N, Nguyen J, Chen C. et al. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg 2011; 113: 1353-1364
    CrossrefPubMedGoogle Scholar
  • 29 Ecimovic P, Murray D, Doran P. et al. Direct effect of morphine on breast cancer cell function in vitro: Role of the NET1 gene. Br J Anaesth 2011; 107: 916-923
    CrossrefPubMedGoogle Scholar
  • 30 Hieber S, Huhn R, Hollmann MW. et al. Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 2009; 26: 201-206
    CrossrefPubMedGoogle Scholar
  • 31 Kawaraguchi Y, Horikawa YT, Murphy AN. et al. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology 2011; 115: 499-508
    CrossrefPubMedGoogle Scholar
  • 32 Wu GJ, Chen WF, Sung CS. et al. Isoflurane attenuates dynorphin-induced cytotoxicity and downregulation of Bcl-2 expression in differentiated neuroblastoma SH-SY5Y cells. Acta Anaesthesiol Scand 2009; 53: 55-60
    CrossrefPubMedGoogle Scholar
  • 33 Miao Y, Zhang Y, Wan H. et al. GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed Pharmacother 2010; 64: 583-588
    CrossrefPubMedGoogle Scholar
  • 34 Mammoto T, Mukai M, Mammoto A. et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 2002; 184: 165-170
    CrossrefPubMedGoogle Scholar
  • 35 Karnezis T, Shayan R, Caesar C. et al. VEGF-D Promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012; 21: 181-195
    CrossrefPubMedGoogle Scholar
  • 36 Hussain M, Javeed A, Ashraf M. et al. Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy. Pharmacol Res 2012; 66: 7-18
    CrossrefPubMedGoogle Scholar
  • 37 Singh B, Berry J, Shoher A. et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene 2007; 26: 3789-3796
    CrossrefPubMedGoogle Scholar
  • 38 Singh B, Berry JA, Shoher A. et al. COX-2 induces IL-11 production in human breast cancer cells. In: J. Surg. Res 2006; 267-275
    PubMedGoogle Scholar
  • 39 Singh B, Cook KR, Vincent L. et al. Role of COX-2 in tumorospheres derived from a breast cancer cell line. J Surg Res 2011; DOI: 10.1016/j.jss.2010.03.003.
    CrossrefPubMedGoogle Scholar
  • 40 Tsujii M. Cyclooxygenase, cancer stem cells and dna methylation play important roles in colorectal carcinogenesis. In: Digestion 2013; pp 12-16
    PubMedGoogle Scholar
  • 41 Guo YC, Chang CM, Hsu WL. et al. Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization. Molecules 2013; 18: 6584-6596
    CrossrefPubMedGoogle Scholar
  • 42 Brand L, Munding J, Pox CP. et al. ß-catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy. Int J Colorectal Dis 2013; 28: 1091-1098
    CrossrefPubMedGoogle Scholar
  • 43 Rothwell PM, Price JF, Fowkes FGR. et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379: 1602-1612
    CrossrefPubMedGoogle Scholar
  • 44 Jacobs EJ, Newton CC, Gapstur SM. et al. Daily aspirin use and cancer mortality in a large US Cohort. J Natl Cancer Inst 2012; 104: 1208-1217
    CrossrefPubMedGoogle Scholar
  • 45 Singleton PA, Mirzapoiazova T, Hasina R. et al. Increased ??-opioid receptor expression in metastatic lung cancer. Br J Anaesth 2014; DOI: 10.1093/bja/aeu165.
    CrossrefPubMedGoogle Scholar
  • 46 Zylla D, Kuskowski Ma, Gupta K. et al. Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer. Br J Anaesth 2014; 1-8
    PubMedGoogle Scholar
  • 47 Mathew B, Lennon FE, Siegler J. et al. The novel role of the mu opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg 2011; 112: 558-567
    CrossrefPubMedGoogle Scholar
  • 48 Byrne K, Levins KJ, Buggy DJ. Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis?. Canadian Journal of Anesthesia/ Journal canadien d'anesthésie 2016; 63: 184-192
    PubMedGoogle Scholar
  • 49 Nguyen J, Luk K, Vang D. et al. Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Br J Anaesth 2014; DOI: 10.1093/bja/aeu090.
    CrossrefPubMedGoogle Scholar
  • 50 Desmond F, McCormack J, Mulligan N. et al. Effect of anaesthetic technique on immune cell infiltration in breast cancer: A follow-up pilot analysis of a prospective, randomised, investigator-masked study. Anticancer Res 2015; 35: 1311-1320
    PubMedGoogle Scholar
  • 51 Ma D, Lim T, Xu J. et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009; 20: 713-720
    CrossrefPubMedGoogle Scholar
  • 52 De Hert SG, Turani F, Mathur S. et al. Cardioprotection with volatile anesthetics: Mechanisms and clinical implications. Anesth Analg 2005; 100: 1584-1593
    CrossrefPubMedGoogle Scholar
  • 53 Weidemann a, Johnson RS. Biology of HIF-1alpha. Cell Death Differ 2008; 15: 621-627
    CrossrefPubMedGoogle Scholar
  • 54 McCausland K, Martin N, Missair A. Anaesthetic technique and cancer recurrence: current understanding. risk.1:0.0001
    PubMed
  • 55 Patel SA, Simon MC. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 2008; 15: 628-634
    CrossrefPubMedGoogle Scholar
  • 56 Tavare AN, Perry NJS, Benzonana LL. et al. Cancer recurrence after surgery: Direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237-1250
    CrossrefPubMedGoogle Scholar
  • 57 Boughey JC. 2-23 Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?. Breast Dis 2007; 18: 162-163
    PubMedGoogle Scholar
  • 58 Wuethrich PY, Hsu Schmitz S-F, Kessler TM. et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: A retrospective study. Anesthesiology 2010; 113: 570-576
    CrossrefPubMedGoogle Scholar
  • 59 Ismail H, Ho KM, Narayan K. et al. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: A retrospective cohort study. Br J Anaesth 2010; 105: 145-149
    CrossrefPubMedGoogle Scholar
  • 60 Gupta A, Björnsson A, Fredriksson M. et al. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: A retrospective analysis of data from 655 patients in Central Sweden. Br J Anaesth 2011; 107: 164-170
    CrossrefPubMedGoogle Scholar
  • 61 Lin L, Liu C, Tan H. et al. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: A retrospective analysis. Br J Anaesth 2011; 106: 814-822
    CrossrefPubMedGoogle Scholar
  • 62 de Oliveira GS, Ahmad S, Schink JC. et al. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 2011; 36: 271-277
    CrossrefPubMedGoogle Scholar
  • 63 Lai R, Peng Z, Chen D. et al. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg 2012; 114: 290-296
    CrossrefPubMedGoogle Scholar
  • 64 Day A, Smith R, Jourdan I. et al. Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. Br J Anaesth 2012; 109: 185-190
    CrossrefPubMedGoogle Scholar
  • 65 Gottschalk A, Brodner G, Van Aken HK. et al. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma?. Br J Anaesth 2012; 109: 253-259
    CrossrefPubMedGoogle Scholar
  • 66 Christopherson R, James KE, Tableman M. et al. Long-term survival after colon cancer surgery: A variation associated with choice of anesthesia. Anesth Analg 2008; 107: 325-332
    CrossrefPubMedGoogle Scholar
  • 67 Myles PS, Peyton P, Silbert B. et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 2011; 342: d1491
    CrossrefPubMedGoogle Scholar
  • 68 Tsui BCH, Rashiq S, Schopflocher D. et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010; 57: 107-112
    CrossrefPubMedGoogle Scholar
  • 69 Cummings 3rd KC. CG A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: A population-based study. Anesthesiology 2012; 116: 797-806
    CrossrefPubMedGoogle Scholar